Chinese | English
HFCAS OpenIR
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
Wang, Wenxian1; Wang, Qian2; Xu, Chunwei3,4; Li, Ziming5; Song, Zhengbo1; Zhang, Yongchang6; Cai, Xiuyu7; Zhang, Shirong8; Lian, Bin9; Li, Wen10; Liu, Anwen11; Zhan, Ping4; Liu, Hongbing4; Lv, Tangfeng4; Miao, Liyun12; Min, Lingfeng13; Chen, Yu14,15; Yuan, Jingping16; Wang, Feng17; Jiang, Zhansheng18; Lin, Gen14,15; Pu, Xingxiang19,20; Rao, Chuangzhou21; Lv, Dongqing22; Yu, Zongyang23; Li, Xiaoyan24; Tang, Chuanhao25; Zhou, Chengzhi26; Xie, Congying27; Zhang, Junping28; Guo, Hui29; Chu, Qian30; Meng, Rui31; Wu, Jingxun32; Zhang, Rui33; Wang, Liping34; Zhu, Youcai35; Hu, Xiao36; Xie, Yanru37; Lin, Xinqing26; Cai, Jing11; Lan, Fen10; Feng, Huijing28; Wang, Lin38; Yao, Wang39; Shi, Xuefei40; Huang, Jianhui37; Chen, Huafei35; Zhang, Yinbin41; Sun, Pingli42; Wan, Bing43; Pang, Fei44; Xu, Zanmei44; Wang, Kai44; Xia, Yuanli45; Ye, Mingxiang4; Wang, Dong4; Wei, Qing1; Feng, Shuitu46; Zhou, Jianya47; Zhang, Jiexia26; Lv, Donglai48; Gao, Wenbin49; Kang, Jing50; Yu, Genhua51; Liang, Xianbin52; Yu, Chengtao53; Shi, Lin54; Yang, Nong6; Wu, Lin19,20; Hong, Zhuan55; Hong, Wei1; Fang, Meiyu1; Zhang, Yiping1; Lu, Yuanzhi56; Wang, Guansong57; Ma, Shenglin58; Si, Lu9; Fang, Wenfeng59; Song, Yong4
2022-10-21
Source PublicationTHORACIC CANCER
ISSN1759-7706
Corresponding AuthorSi, Lu(silu15_silu@126.com) ; Fang, Wenfeng(fangwf@sysucc.org.cn) ; Song, Yong(yong.song@nju.edu.cn)
AbstractImmune checkpoint inhibitors (ICIs) have successfully treated a number of different types of cancer, which is of great significance for cancer treatment. With the widespread use of ICIs in clinical practice, the increasing checkpoint inhibitor pneumonia (CIP) will be a challenge to clinicians. To guide the diagnosis and treatment of CIP, we conducted in-depth discussions based on the latest evidence, forming a consensus among Chinese experts on the multidisciplinary management of CIP.
Keywordcheckpoint inhibitor pneumonitis Chinese experts consensus immune checkpoint inhibitor-related adverse effects
DOI10.1111/1759-7714.14693
WOS KeywordCELL LUNG-CANCER ; ADVERSE EVENTS ; PD-1/PD-L1 INHIBITORS ; SAFETY ; EFFICACY ; IMMUNOTHERAPY ; ANTI-PD-1 ; MELANOMA ; NSCLC ; CHEMOTHERAPY
Indexed BySCI
Language英语
WOS Research AreaOncology ; Respiratory System
WOS SubjectOncology ; Respiratory System
WOS IDWOS:000877840500001
PublisherWILEY
Citation statistics
Cited Times:1[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.hfcas.ac.cn:8080/handle/334002/130207
Collection中国科学院合肥物质科学研究院
Corresponding AuthorSi, Lu; Fang, Wenfeng; Song, Yong
Affiliation1.Chinese Acad Sci Univ Canc Hosp, Dept Chemotherapy, Zhejiang Canc Hosp, Hangzhou, Peoples R China
2.Nanjing Univ Chinese Med, Jiangsu Prov Hosp Chinese Med, Dept Resp Med, Affiliated Hosp, Nanjing, Peoples R China
3.Chinese Acad Sci, Inst Canc & Basic Med ICBM, Hangzhou, Peoples R China
4.Nanjing Univ, Affiliated Jinling Hosp, Dept Resp Med, Med Sch, Nanjing 210002, Jiangsu, Peoples R China
5.Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Shanghai Lung Canc Ctr, Shanghai, Peoples R China
6.Cent South Univ, Dept Med Oncol,Xiangya Sch Med, Lung Canc & Gastrointestinal Unit, Hunan Canc Hosp,Affiliated Canc Hosp, Changsha, Peoples R China
7.Sun Yet Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept VIP Inpatient, State Key Lab Oncol South China, Guangzhou, Peoples R China
8.Zhejiang Univ, Translat Med Res Ctr, Key Lab Clin Canc Pharmacol & Toxicol Res Zhejian, Affiliated Hangzhou Peoples Hosp 1,Canc Ctr, Hangzhou, Peoples R China
9.Peking Univ Canc Hosp & Inst, Dept Melanoma & Sarcoma, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Beijing, Peoples R China
10.Zhejiang Univ, Key Lab Resp Dis Zhejiang Prov, Dept Resp & Crit Care Med, Affiliated Hosp 2,Sch Med,Canc Ctr, Hangzhou, Peoples R China
11.Nanchang Univ, Dept Oncol, Affiliated Hosp 2, Nanchang, Peoples R China
12.Nanjing Univ, Dept Resp Med, Affiliated Drum Tower Hosp, Med Sch, Nanjing, Peoples R China
13.Yangzhou Univ, Subei Peoples Hosp Jiangsu Prov, Dept Resp Med, Clin Med Sch, Yangzhou, Jiangsu, Peoples R China
14.Fujian Med Univ Canc Hosp, Dept Med Oncol, Fuzhou, Peoples R China
15.Fujian Canc Hosp, Fuzhou, Peoples R China
16.Wuhan Univ, Dept Pathol, Renmin Hosp, Wuhan, Peoples R China
17.Nanjing Univ, Affiliated Jinling Hosp, Canc Ctr PLA, Dept Internal Med,Med Sch,Qinhuai Med Area, Nanjing, Peoples R China
18.Tianjin Med Univ Canc Inst & Hosp, Dept Integrat Oncol, Tianjin, Peoples R China
19.Cent South Univ, Dept Med Oncol, Lung Canc, Xiangya Sch Med, Changsha, Peoples R China
20.Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Hunan Canc Hosp, Changsha, Peoples R China
21.Univ Chinese Acad Sci, Hwamei Hosp, Dept Radiotherapy & Chemotherapy, Ningbo, Peoples R China
22.Wenzhou Med Univ, Dept Pulm Med, Taizhou Hosp, Taizhou, Peoples R China
23.Fujian Med Univ, Hosp 900, Dept Resp Med, Joint Logist Team,Fuzhou Gen Hosp, Fuzhou, Peoples R China
24.Capital Med Univ, Beijing Tiantan Hosp, Dept Oncol, Beijing, Peoples R China
25.Peking Univ Int Hosp, Dept Med Oncol, Beijing, Peoples R China
26.Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth,Affiliated Hosp 1, Guangzhou, Peoples R China
27.Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, Wenzhou, Peoples R China
28.Shanxi Acad Med Sci, Shanxi Bethune Hosp, Dept Thorac Oncol, Taiyuan, Peoples R China
29.Xi An Jiao Tong Univ, Dept Med Oncol, Affiliated Hosp 1, Xian, Peoples R China
30.Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Tongji Med Coll, Wuhan, Peoples R China
31.Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan, Peoples R China
32.Xiamen Univ, Affiliated Hosp Med 1, Dept Med Oncol, Xiamen, Peoples R China
33.China Med Univ, Dept Med Oncol, Canc Hosp, Shenyang, Peoples R China
34.Baotou Canc Hosp, Dept Oncol, Baotou, Peoples R China
35.Jiaxing Univ, Affiliated Hosp 3, Zhejiang Rongjun Hosp, Dept Thorac Dis,Diag & Treatment Ctr, Jiaxing, Peoples R China
36.Univ Chinese Acad Sci, Zhejiang Key Lab Radiat Oncol, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China
37.Lishui Municipal Cent Hosp, Dept Oncol, Lishui, Peoples R China
38.Shanxi Acad Med Sci, Shanxi Bethune Hosp, Dept Pathol, Taiyuan, Peoples R China
39.Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou, Peoples R China
40.Zhejiang Univ, Huzhou Hosp, Dept Resp Med, Sch Med, Huzhou, Peoples R China
41.Xi An Jiao Tong Univ, Med Coll, Dept Oncol, Affiliated Hosp 2, Xian, Peoples R China
42.Second Hosp Jilin Univ, Dept Pathol, Changchun, Peoples R China
43.Nanjing Med Univ, Dept Resp Med, Affiliated Jiangning Hosp, Nanjing, Peoples R China
44.Shanghai OrigiMed Co Ltd, Dept Med, Shanghai, Peoples R China
45.AstraZeneca China, Dept Med Affairs, Shanghai, Peoples R China
46.Xiamen Haicang Hosp, Dept Oncol, Xiamen, Peoples R China
47.Zhejiang Univ, Affiliated Hosp 1, Thorac Dis Ctr, Sch Med, Hangzhou, Peoples R China
48.Joint Logist Support Force People Liberat Army, Dept Clin Oncol, Hosp 901, Hefei, Peoples R China
49.Shenzhen Univ, Dept Oncol, Affiliated Hosp 3, Shenzhen, Peoples R China
50.Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangdong Prov Lab Translat Med Lung Canc, Guangdong Prov Peoples Hosp,Sch Med, Guangzhou, Peoples R China
51.Zhebei Mingzhou Hosp, Dept Radiat Oncol, Huzhou, Peoples R China
52.Third Peoples Hosp Zhengzhou, Dept Oncol, Zhengzhou, Peoples R China
53.Collaborat Innovat Ctr Jiangsu Prov Canc Prevent, Nanjing, Peoples R China
54.Fudan Univ, Zhongshan Hosp, Dept Resp Med, Shanghai, Peoples R China
55.Nanjing Med Univ, Jiangsu Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Nanjing, Peoples R China
56.Jinan Univ, Dept Clin Pathol, Affiliated Hosp 1, Guangzhou, Peoples R China
57.Third Mil Med Univ, Xinqiao Hosp, Inst Resp Dis, Chongqing, Peoples R China
58.Zhejiang Univ, Sch Med, Canc Ctr,Key Lab Clin Canc Pharmacol & Toxicol Re, Affiliated Hangzhou Canc Hosp,Dept Oncol, Hangzhou, Peoples R China
59.Sun Yat Sen Univ Canc Ctr, Dept Med Oncol, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China
Recommended Citation
GB/T 7714		 Wang, Wenxian,Wang, Qian,Xu, Chunwei,et al. Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor[J]. THORACIC CANCER,2022.
APA Wang, Wenxian.,Wang, Qian.,Xu, Chunwei.,Li, Ziming.,Song, Zhengbo.,...&Song, Yong.(2022).Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor.THORACIC CANCER.
MLA Wang, Wenxian,et al."Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor".THORACIC CANCER (2022).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Wang, Wenxian]'s Articles
[Wang, Qian]'s Articles
[Xu, Chunwei]'s Articles
Baidu academic
Similar articles in Baidu academic
[Wang, Wenxian]'s Articles
[Wang, Qian]'s Articles
[Xu, Chunwei]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Wang, Wenxian]'s Articles
[Wang, Qian]'s Articles
[Xu, Chunwei]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.